USANA Health Sciences (USNA) Tops Q2 EPS by 16c; Reiterates Guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $21.98 -0.23%
Revenue Growth %: -0.4%
Financial Fact:
Other, net: -24K
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: -0.4%
Financial Fact:
Other, net: -24K
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.87, $0.16 better than the analyst estimate of $1.71. Revenue for the quarter came in at $336.8 million versus the consensus estimate of $332.61 million.
GUIDANCE:
Reiterates 2021 net sales and diluted EPS outlook.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- Delta Air shares slip despite strong outlook, Melius says
- Ionis Pharmaceuticals (IONS) reaffirms guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
